SCHEMBL10148767

SCHEMBL10148767

CCC1O[C@H](C)C(C)[C@H](OCc2ccccc2)[C@@H]1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 2/20 0.42
MTOR P42345 1/20 0.42
TACR2 P21452 3/20 0.40
BCHE P06276 1/20 0.40
SSTR1 P30872 1/20 0.39
SSTR2 P30874 1/20 0.39
SSTR4 P31391 1/20 0.39
SSTR3 P32745 1/20 0.39
SSTR5 P35346 1/20 0.39
FGF1 P05230 2/20 0.36
FGF2 P09038 2/20 0.36
VEGFA P15692 2/20 0.36
HPSE Q9Y251 2/20 0.36
HTR1A P08908 1/20 0.36
NT5E P21589 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18573702 0.89 PDPK1 (0.43) PDPK1MTORTACR2BCHESSTR1
SCHEMBL769692 0.88 PDPK1 (0.39) PDPK1MTORTACR2BCHESSTR1
SCHEMBL14850038 0.88 PDPK1 (0.39) PDPK1MTORTACR2BCHESSTR1
SCHEMBL10148770 0.87 SSTR1 (0.39) PDPK1MTORTACR2BCHESSTR1
SCHEMBL26273822 0.86 PDPK1 (0.40) PDPK1MTORTACR2BCHESSTR1
SCHEMBL17320855 0.85 HTR1A (0.50) TACR2BCHESSTR1SSTR2SSTR4
SCHEMBL17773520 0.85 PDPK1 (0.39) PDPK1MTORTACR2BCHESSTR1
SCHEMBL13129923 0.84 PDPK1 (0.46) PDPK1MTORBCHESSTR1SSTR2
SCHEMBL13129892 0.84 PDPK1 (0.46) PDPK1MTORBCHESSTR1SSTR2
SCHEMBL19726196 0.84 PDPK1 (0.46) PDPK1MTORBCHESSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114970-B2 Synthetic heparin monosaccharides ALCHEMIA LIMITED (AU) 2012-02-14 US disclosed
US-20090187013-A1 SYNTHETIC HEPARIN PENTASACCHARIDES ALCHEMIA LIMITED (AU) 2009-07-23 US disclosed
US-7541445-B2 Synthetic heparin pentasaccharides ALCHEMIA LIMITED (AU) 2009-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090187013-A1 SYNTHETIC HEPARIN PENTASACCHARIDES HPSE, DDOST, STT3A PDPK1 4122/4885MTOR 3021/4885TACR2 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.